/
بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق
بحث بيانات أعضاء هيئة التدريس
facebook
youtube
googleplus
twitter
zagazig
En
الموقع الشخصى
السيرة الذاتية
هشام عبدالمنعم عبدالحميدعباس
الكلية الصيدلة - القسم الميكروبيولوجى والمناعة
الدرجات العلمية
بكالوريوس فى الميكروبيولوجي والمناعه, -جامعة الزقازيق [1998]
ماجستير فى الميكروبيولوجي والمناعه, -جامعة الزقازيق [2007]
دكتوراه فى الميكروبيولوجي والمناعه, -جامعة الزقازيق [2011]
الحالة الوظيفية الحالية :
قائم بالعمل
التدرج الوظيفى الأكاديمى
معيد : 16/9/1998
مدرس مساعد : 27/3/2007
مدرس : 24/1/2012
أستاذ مساعد : 26/6/2018
أستاذ : 25/7/2023
الأبحاث العلمية
1 -
Combating Pseudomonas aeruginosa Biofilms by Potential Biofilm Inhibitors (1433).
2 -
N-acetylcysteine and Ambroxol: can mucolytics dissolve the resistance of biofilms to antibiotics (1433).
3 -
Non-steroidal anti-inflammatory drugs and sodium ascorbate potentiate the antibiotic activity against Pseudomonas aeruginosa biofilms (1433).
4 -
Comparative assessment of biofilm formation of Pseudomonas aeruginosa isolates by crystal violet assay and viable count assay (1433).
5 -
Synergic interaction between antibiotics and the artificial sweeteners xylitol and sorbitol against Pseudomonas aeruginosa biofilms (1434).
6 -
Modulation of antibiotic activity against Pseudomonas aeruginosa by N-acetylcysteine, ambroxol and ascorbic acid (1434).
7 -
Biofilms: The Microbial Castle of Resistance (1434).
8 -
Ambroxol blocks swarming and swimming motilities and inhibits biofilm formation by Proteus mirabilis isolated from diabetic foot infection (1434).
9 -
Antibacterial, Anti-swarming and Antibiofilm Activities of Local Egyptian Clover Honey Against Proteus Mirabilis Isolated from Diabetic Foot Infection (1434).
10 -
BACTERIAL ETIOLOGY AND ANTIMICROBIAL RESISTANCE OF BURN WOUND INFECTIONS IN A BURN UNIT IN HEHIA GENERAL HOSPITAL IN EGYPT (1435).
11 -
In vitro Antibacterial and Antibiofilm Activities of Hibiscus sabdariffa L. Extract and Apple Vinegar against Bacteria Isolated from Diabetic Foot Infections (1435).
12 -
Study of Antibacterial Activity of Some Plant Extracts Against Enterohemorrhagic Escherichia coli O157:H7 (1434).
13 -
In vitro activity of antibiotic combination against biofilm-forming Pseudomonas aeruginosa (1433).
14 -
Comparative Antibacterial and Antibiofilm Activities of Manuka Honey and Egyptian Clover Honey (1435).
15 -
Diabetic foot infections in Zagazig University Hospital: bacterial etiology, antimicrobial resistance and biofilm formation (1435).
16 -
Allium kurrat and Eruca sativa are Natural agents for Inhibition and Eradication of Enterohemorrhagic Escherichia coli O157:H7 Biofilm (1435).
17 -
Eradication of biofilms formed by bacteria isolated from diabetic foot infections by potential antibiofilm agents alone and in combination with ciprofloxacin (1435).
18 -
Diabetic Foot infection (1436).
19 -
Inhibition of Virulence of Pseudomonas aeruginosa: A Novel Role of Metronidazole Against Aerobic Bacteria (1437).
20 -
INHIBITION OF VIRULENCE FACTORS OF PSEUDOMONAS AERUGINOSA BY DICLOFENAC SODIUM (1437).
21 -
Glyceryl trinitrate is a novel inhibitor of quorum sensing in Pseudomonas aeruginosa (1438).
22 -
Resistance of Escherichia coli and Klebsiella pneumoniae isolated from different Sources to β-lactam Antibiotics (1438).
23 -
Evaluation of the role of SsaV ‘Salmonella pathogenicity island-2 dependent type III secretion system components on the virulence behavior of Salmonella enterica serovar Typhimurium (1438).
24 -
Repurposing metformin as a quorum sensing inhibitor in Pseudomonas aeruginosa (1438).
25 -
Targeting the virulence factors of Serratia marcescens by ambroxol (1438).
26 -
Silencing the nosocomial pathogen Serratia marcescens by glyceryl trinitrate (1439).
27 -
Phenotypic and genotypic detection of antibiotic resistance of Pseudomonas aeruginosa isolated from urinary tract infections (1439).
28 -
Perturbation of Quorum Sensing in Pseudomonas aeruginosa by Febuxostat (1439).
29 -
Elimination of multidrug resistant Proteus mirabilis biofilms using bacteriophages (1440).
30 -
Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates (1440).
31 -
Repositioning secnidazole as a novel virulence factors attenuating agent in Pseudomonas aeruginosa (1440).
32 -
Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus (1440).
33 -
Zinc oxide nanoparticles inhibits quorum sensing and virulence in Pseudomonas aeruginosa (1440).
34 -
Curtailing Quorum Sensing in Pseudomonas aeruginosa by Sitagliptin (1441).
35 -
Diclofenac mitigates virulence of multidrug‑resistant Staphylococcus aureus (1441).
36 -
Sotolon is a natural virulence mitigating agent in Serratia marcescens (1442).
37 -
An innovative role for tenoxicam as a quorum sensing inhibitor in Pseudomonas aeruginosa (1441).
38 -
Synthesis of imidazolidine‐2,4‐dione and 2‐thioxoimidazolidin‐4‐one derivatives as inhibitors of virulence factors production in Pseudomonas aeruginosa (1441).
39 -
Repurposing anti-diabetic drug “Sitagliptin” as a novel virulence attenuating agent in Serratia marcescens (1441).
40 -
Polyphenols from Salix tetrasperma Impair Virulence and Inhibit Quorum Sensing of Pseudomonas aeruginosa (1441).
41 -
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2 (1442).
42 -
Sensitizing multi drug resistant Staphylococcus aureus isolated from surgical site infections to antimicrobials by efflux pump inhibitors (1442).
43 -
Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation (1442).
44 -
Not Only Antimicrobial: Metronidazole Mitigates the Virulence of Proteus mirabilis Isolated from Macerated Diabetic Foot Ulcer (1442).
45 -
Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens (1442).
46 -
Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon (1442).
47 -
Secnidazole Is a Promising Imidazole Mitigator of Serratia marcescens Virulence (1443).
48 -
The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus (1443).
49 -
Anti-diabetics and antimicrobials: Harmony of mutual interplay (1443).
50 -
Impeding Virulence of Candida albicans by Candesartan and Domperidone (1443).
51 -
Sotolon is a natural virulence mitigating agent in Serratia marcescens (1443).
52 -
A NEW ROLE OF METFORMIN AS AN EFFLUX PUMP INHIBITOR IN KLEBSIELLA PNEUMONIA (1442).
53 -
A novel use of allopurinol as a quorum sensing inhibitor in Pseudomonas aeruginosa (1443).
54 -
Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients (1443).
55 -
The Role of Haemolysin Transport System in Antimicrobial Resistance of Haemolytic Strains of Escherichia coli and the Effect of Potential Efflux Inhibitors (1429).
56 -
Antimicrobial resistance patterns of Proteus mirabilis isolates from urinary tract, burn wound and diabetic foot infections (1439).
57 -
) Phenotypic and genotypic characterization of Pseudomonas aeruginosa siderophores (1439).
58 -
Prevalence of multi-drug resistant Staphylococci isolated from surgical site infections (1439).
59 -
Antimicrobial Susceptibility and Resistance Profile of Pseudomonas aeruginosa Isolates from Patients at an Egyptian Hospital (1439).
60 -
Impeding efflux-mediated resistance in Staphylococcus aureus (1444).
61 -
Knocking down Pseudomonas aeruginosa virulence by oral hypoglycemic metformin nano emulsion (1443).
62 -
Novel silver metformin nano-structure to impede virulence of Staphylococcus aureus (1443).
63 -
Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis (1444).
64 -
Attenuating the virulence of the resistant superbug Staphylococcus aureus bacteria isolated from neonatal sepsis by ascorbic acid, dexamethasone, and sodium bicarbonate (1444).
65 -
Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa (1443).
66 -
Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus (1443).
67 -
Promising FDA-approved drugs with efflux pump inhibitory activities against clinical isolates of Staphylococcus aureus (1443).
68 -
GC-MS Analysis and Microbiological Evaluation of Caraway Essential Oil as a Virulence Attenuating Agent against Pseudomonas aeruginosa (1444).
69 -
Synthesis of imidazolidine‐2,4‐dione and 2‐thioxoimidazolidin‐4‐one derivatives as inhibitors of virulence factors production in Pseudomonas aeruginosa (1441).
70 -
Alleviating the virulence of Pseudomonas aeruginosa and Staphylococcus aureus by ascorbic acid nanoemulsion (1444).
71 -
Study on the control of biofilm formation in clinical multidrug resistant Proteus mirabilis isolates (1445).
72 -
Synthesis of some nanomaterials and evaluation of their activity against Staphylococcus aureus and Pseudomonas aeruginosa (1445).
73 -
Prevalence and control of carbapenemases among the clinical isolates of Klebsiella pneumoniae and Escherichia coli (1445).
74 -
Inhibition of virulence factors in multi-drug resistant Pseudomonas aeruginosa (1445).
75 -
Study on the inter and intrageneric transmission of drug resistant determinants (1445).
76 -
Repurposing of some non-antimicrobial FDA approved drugs to combat antimicrobial resistance and virulence of some pathogenic microbes (1445).
77 -
Study on strategies to combat antibiotic resistance in clinical isolates of Staphylococcus aureus (1445).
78 -
Targeting virulence factors among pathogenic bacteria isolated from neonates with sepsis (1445).
79 -
Detection and typing of siderophores produced by Pseudomonas aeruginosa isolates (1445).
80 -
Studies on multidrug resistant bacteria isolated from burn wound infections (1445).
81 -
Inhibition of efflux pumps in Klebsiella pneumoniae isolated from patients with respiratory tract infection (1445).
82 -
Inhibition of virulence factors of methicillin-resistant Staphylococcus aureus (1445).
83 -
Diminishing the Pathogenesis of the Food-Borne Pathogen Serratia marcescens by Low Doses of Sodium Citrate (1444).
84 -
Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems (1444).
85 -
Crippling of Klebsiella pneumoniae virulence by metformin, N-acetylcysteine and secnidazole (1445).
86 -
Relocating Glyceryl Trinitrate as an Anti-Virulence Agent against Pseudomonas aeruginosa and Serratia marcescens: Insights from Molecular and In Vivo Investigations (1445).
87 -
Inhibition of virulence factors of Proteus mirabilis isolated from urinary tract infection, diabetic foot infections and burn wound infections (1445).
88 -
In vitro activity of tigecycline against local clinical isolates of Enterobacteriacae (1445).
89 -
Efflux pump as a mechanism of resistance to antimicrobials in gram positive bacteria isolated from surgical site infections (SSIs) (1445).
90 -
The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model (1445).
91 -
Celastrol boosts fluconazole efficacy against vaginal candidiasis: in vitro and in vivo evidence (1446).
92 -
Cilostazol is a promising anti-pseudomonal virulence drug by disruption of quorum sensing (1446).
93 -
Redirecting pantoprazole as a metallo-beta-lactamase inhibitor in carbapenem-resistant Klebsiella pneumoniae (1445).
94 -
Utilization of zein nano-based system for promoting antibiofilm and anti-virulence activities of curcumin against Pseudomonas aeruginosa (1445).
المجالات البحثية
Antibiotic resistance
antivirulence therapy
Biofilm infection
Diabetic foot infection
Quorum sensing inhibition
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
شراقوة | الشرقية بين ايديك
اخبار الشرقية - شراقوة | الشرقية بين ايديك
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف
